EastWest Bioscience Inc.

EAST.H

CA27783V1076

Other Specialty Retailers

Delayed Toronto S.E. Other stock markets 09:54:31 28/04/2023 am IST			5-day change	1st Jan Change
0.025 ^CAD	-.--%		-.--%	-.--%

2022	EastWest Bioscience Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	CI
2022	EastWest Bioscience Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	CI

EastWest Bioscience Inc. Announces Earnings Results for the Third Quarter Ended April 30, 2021

June 29, 2021 at 02:49 am IST

EastWest Bioscience Inc. announced earnings results for the third quarter ended April 30, 2021. For the third quarter, the company announced total revenue was CAD 310,980 compared to CAD 231,248 a year ago. Net loss was CAD 151,866 compared to CAD 374,690 a year ago. For the nine months, total revenue was CAD 935,198 compared to CAD 1.107 million a year ago. Net loss was CAD 671,454 compared to CAD 841,062 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.

Latest news about EastWest Bioscience Inc.

EastWest Bioscience Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	29/22/29	CI
EastWest Bioscience Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	01/22/01	CI
EastWest Bioscience Inc. Reports Earnings Results for the First Quarter Ended October 31, 2021	30/21/30	CI
EastWest Bioscience Inc. Reports Earnings Results for the Full Year Ended July 31, 2021	03/21/03	CI
EastWest Bioscience Inc. Auditor Raises 'Going Concern' Doubt	03/21/03	CI
EastWest Bioscience Inc. Adds Oliver to Its Self-Storage Location Portfolio	24/21/24	CI
EastWest Bioscience Inc. Adds Self-Storage to Penticton Facility	04/21/04	CI
EastWest Bioscience Inc. Announces Earnings Results for the Third Quarter Ended April 30, 2021	29/21/29	CI
EastWest Bioscience Inc. Restructures Workforce by Reducing Number of Staff and Focusing on Automation and Streamlining Existing Processes	01/21/01	CI
Eastwest Bioscience Inc. Reports Earnings Results for the First Quarter Ended October 31, 2020	16/21/16	CI
Eastwest Bioscience Inc. Announces Executive Changes	06/21/06	CI
Eastwest Bioscience Inc. Reports Earnings Results for the Full Year Ended July 31, 2020	30/20/30	CI
EastWest Bioscience Inc. Auditor Raises 'Going Concern' Doubt	29/20/29	CI
EastWest Bioscience Group Announces Executive Changes at Sangsters Health Centre	22/20/22	CI
Eastwest Bioscience Inc. Reports Earnings Results for the Third Quarter Ended April 30, 2020	29/20/29	CI
EastWest Bioscience Inc. announced that it has received CAD 0.099636 million in funding	25/20/25	CI
EastWest Bioscience Inc. announced that it expects to receive CAD 0.1 million in funding	18/20/18	CI
EastWest Bioscience Inc. completed the acquisition of remaining 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. from Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp.	11/20/11	CI
Eastwest Bioscience Inc. Reports Earnings Results for the First Quarter Ended October 31, 2019	10/20/10	CI
EastWest Bioscience Inc. Announces the Construction Completed on Eastwest's Kentucky, USA CBD Processing and Bottling Line	06/20/06	CI
Eastwest Bioscience Inc. Reports Earnings Results for the Full Year Ended July 31, 2019	29/20/29	CI
EastWest Bioscience Inc. agreed to acquire remaining 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. from Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp. for CAD 0.08 million.	18/19/18	CI
Eastwest Bioscience Group Continues Expansion into the US Market with the Construction on its CBD Processing and Bottling Line Nearing Completion	27/19/27	CI
InnerScope Hearing Technologies Inc. Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE INCBioscience Inc	06/19/06	CI
EastWest Bioscience Inc. Completes First Production Run of CBD Pet Treats for the US Market	30/19/30	CI

Chart EastWest Bioscience Inc.

Duration

Period

More charts

Company Profile

Eastwest Bioscience Inc. is a Canada-based vertically integrated wellness company. The Company has a multitude of business units and assets that allow for seed-to-sale supply chain management. The Company sources its raw materials, processes, manufactures, tests, brands, markets and distributes its products to its customers in Canada, the United States, and other countries. The Company owns and operates retail and manufacturing subsidiaries. Its retail subsidiary is a Canada-based natural health retail franchise, the Sangster's Health Centre's, which is involved in the health and wellness industry. Orchard Vale Naturals is the Company's manufacturing arm that is certified with a Health Canada Site License and has GMP Certified NHP Manufacturing capabilities. Orchard Vale Naturals is specialized in custom blends and production runs of all sizes, small to large. Orchard Vale Naturals operates out of the approximately 34,000 square Health Canada licensed facility in Penticton, British Col

Sector

Other Specialty Retailers

More about the company

Sector Other Miscellaneous Specialty Retailers

	1st Jan change	Capi.
EASTWEST BIOSCIENCE INC.	-.--%	1.84M
TRACTOR SUPPLY COMPANY	+28.34%	29.59B
AVOLTA AG	+16.08%	6.43B
JARIR MARKETING COMPANY	-13.99%	4.29B
JUMBO S.A.	+11.46%	4.01B
GRUPO GIGANTE, S. A. B. DE C. V.	+4.23%	1.89B
UPBOUND GROUP, INC.	-2.83%	1.8B
WINMARK CORPORATION	-10.79%	1.32B
SALLY BEAUTY HOLDINGS, INC.	-17.70%	1.18B
LESLIE'S, INC.	-22.43%	1.04B

Other Miscellaneous Specialty Retailers